USER ID: 
 PASSWORD: 
Course Overview

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the debate over whether levodopa is potentially neurotoxic to remaining dopaminergic neurons in Parkinson’s disease
  • Recognize the range of motor complications caused by levodopa and the mechanism responsible for their development
  • Recognize the therapeutic usefulness of levodopa in the treatment of Parkinson’s disease
Checking JavaScript. Your browser must support JavaScript in order to use this site. Follow this link to learn how to enabled JavaScript.
 E-mail : 
 User Name : 
 Password : 
Confirm Password : 
 Title : 
 First Name : 
 Last Name : 
 Degree/Certifications (Required for CME) : 
 Practice/Hospital Name : 
 Street Address : 
  : 
 City : 
 State / Province : 
 Zip/Postal Code : 
 Country : 
 Daytime Number : 
 Fax Number : 
 Referred By : 

Account Registration

 required
 not required
 

(c) 2006 The Movement Disorder Society & The Center for Advanced Medical Education. All rights reserved. Privacy Statement